Palasis Maria sold Lyra Therapeutics ($LYRA) shares on the open market twice in the last year for a total of about $20,000, with the most recent sale on January 6, 2026, ranking 11,051st among nearly 12,000 insiders. She also sold Beta Bionics ($BBNX) shares four times for roughly $79,000, most recently on December 1, 2025, ranking 9,889th. These sales are well below the average insider amount of 8.6 million across over six transactions, and Maria made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | Principal Executive Officer | D | Common Stock | 2000 | $0.00 | 1,094,733.0000 | 1,774,882 | 0.18% | 0.11% |
| Jan. 13, 2026 | Beta Bionics, Inc. | $BBNX | Palasis Maria | Not found | A | Common Stock | 3997 | $0.00 | 12,432.0000 | 44,024,631 | 47.39% | 0.01% |
| Jan. 6, 2026 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | President & CEO | S | Common Stock | 1702 | $3.36 | 1,096,733.0000 | 1,774,882 | 0.15% | 0.10% |
| Dec. 1, 2025 | Beta Bionics, Inc. | $BBNX | Palasis Maria | Not found | S | Common Stock | 906 | $29.33 | 8,935.0000 | 44,024,631 | 9.21% | 0.00% |
| Dec. 1, 2025 | Beta Bionics, Inc. | $BBNX | Palasis Maria | Not found | S | Common Stock | 500 | $29.96 | 8,435.0000 | 44,024,631 | 5.60% | 0.00% |
| Oct. 31, 2025 | Beta Bionics, Inc. | $BBNX | Palasis Maria | Not found | S | Common Stock | 119 | $27.45 | 9,841.0000 | 44,024,631 | 1.19% | 0.00% |
| Oct. 31, 2025 | Beta Bionics, Inc. | $BBNX | Palasis Maria | Not found | S | Common Stock | 1287 | $26.86 | 9,960.0000 | 44,024,631 | 11.44% | 0.00% |
| Oct. 1, 2025 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | President & CEO | A | Employee Stock Option (right to buy) | 3667 | $0.00 | 7,333.0000 | 65,880,561 | 100.03% | 0.01% |
| July 10, 2025 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | President & CEO | S | Common Stock | 1565 | $8.91 | 1,098,435.0000 | 65,880,561 | 0.14% | 0.00% |
| March 15, 2025 | Beta Bionics, Inc. | $BBNX | Palasis Maria | Not found | A | Common Stock | 11247 | $0.00 | 11,247.0000 | 43,348,840 | 9999.99% | 0.03% |
| Jan. 31, 2025 | Beta Bionics, Inc. | $BBNX | Palasis Maria | Not found | A | Director Stock Option (right to buy) | 9137 | $0.00 | 9,137.0000 | 0 | 9999.99% | 0.00% |
| Jan. 8, 2025 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | President & CEO | A | Common Stock | 800000 | $0.00 | 1,100,000.0000 | 0 | 266.67% | 0.00% |
| Dec. 9, 2024 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | President & CEO | A | Employee Stock Option (right to buy) | 183333 | $0.00 | 183,333.0000 | 0 | 9999.99% | 0.00% |
| Oct. 16, 2024 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | President & CEO | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| March 18, 2024 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | President & CEO | A | Stock Option | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | President & CEO | A | Stock Option | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | President & CEO | A | Stock Option | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Lyra Therapeutics, Inc. | $LYRA | Palasis Maria | President & CEO | A | Stock Option | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |